In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands - PubMed (original) (raw)

In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands

Ilse Smolders et al. J Neurochem. 2004 Mar.

Free article

Abstract

The effects of several metabotropic receptor (mGluR) ligands on baseline hippocampal glutamate and GABA overflow in conscious rats and the modulation of limbic seizure activity by these ligands were investigated. Intrahippocampal mGluR group I agonist perfusion via a microdialysis probe [1 mm (R,S)-3,5-dihydroxyphenylglycine] induced seizures and concomitant augmentations in amino acid dialysate levels. The mGlu1a receptor antagonist LY367385 (1 mm) decreased baseline glutamate but not GABA concentrations, suggesting that mGlu1a receptors, which regulate hippocampal glutamate levels, are tonically activated by endogenous glutamate. This decrease in glutamate may contribute to the reported LY367385-mediated anticonvulsant effect. The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (50 mg/kg) also clearly abolished pilocarpine-induced seizures. Agonist-mediated actions at mGlu2/3 receptors by LY379268 (100 microm, 10 mg/kg intraperitoneally) decreased basal hippocampal GABA but not glutamate levels. This may partly explain the increased excitation following systemic LY379268 administration and the lack of complete anticonvulsant protection within our epilepsy model with the mGlu2/3 receptor agonist. Group II selective mGluR receptor blockade with LY341495 (1-10 microm) did not alter the rats' behaviour or hippocampal amino acid levels. These data provide a neurochemical basis for the full anticonvulsant effects of mGlu1a and mGlu5 antagonists and the partial effects observed with mGlu2/3 agonists in vivo.

PubMed Disclaimer

Cited by

Effects of microinjections of Group II metabotropic glutamate agents into the amygdala on sleep.
Dong E, Wellman LL, Yang L, Sanford LD. Dong E, et al. Brain Res. 2012 May 3;1452:85-95. doi: 10.1016/j.brainres.2012.03.003. Epub 2012 Mar 8. Brain Res. 2012. PMID: 22453124 Free PMC article.
Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.
Lea PM 4th, Faden AI. Lea PM 4th, et al. CNS Drug Rev. 2006 Summer;12(2):149-66. doi: 10.1111/j.1527-3458.2006.00149.x. CNS Drug Rev. 2006. PMID: 16958988 Free PMC article. Review.
Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility.
De Bundel D, Schallier A, Loyens E, Fernando R, Miyashita H, Van Liefferinge J, Vermoesen K, Bannai S, Sato H, Michotte Y, Smolders I, Massie A. De Bundel D, et al. J Neurosci. 2011 Apr 13;31(15):5792-803. doi: 10.1523/JNEUROSCI.5465-10.2011. J Neurosci. 2011. PMID: 21490221 Free PMC article.
Dysregulation of Ambient Glutamate and Glutamate Receptors in Epilepsy: An Astrocytic Perspective.
Alcoreza OB, Patel DC, Tewari BP, Sontheimer H. Alcoreza OB, et al. Front Neurol. 2021 Mar 22;12:652159. doi: 10.3389/fneur.2021.652159. eCollection 2021. Front Neurol. 2021. PMID: 33828523 Free PMC article. Review.
Astrocyte Glutamate Uptake and Signaling as Novel Targets for Antiepileptogenic Therapy.
Peterson AR, Binder DK. Peterson AR, et al. Front Neurol. 2020 Sep 8;11:1006. doi: 10.3389/fneur.2020.01006. eCollection 2020. Front Neurol. 2020. PMID: 33013665 Free PMC article. Review.

In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands - PubMed (original) (raw)